• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Tuberculosis and its future in the COVID-19 era: The Pulmonology series 2021.

作者信息

Migliori G B, Tiberi S, García-Basteiro A L, Duarte R

机构信息

Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy.

Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK; Division of Infection, Royal London Hospital, Barts Health NHS Trust, London, UK.

出版信息

Pulmonology. 2021 Mar-Apr;27(2):94-96. doi: 10.1016/j.pulmoe.2020.10.005. Epub 2020 Nov 17.

DOI:10.1016/j.pulmoe.2020.10.005
PMID:33272908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7670961/
Abstract
摘要

相似文献

1
Tuberculosis and its future in the COVID-19 era: The Pulmonology series 2021.《结核病及其在新冠疫情时代的未来：2021年肺病学系列》
Pulmonology. 2021 Mar-Apr;27(2):94-96. doi: 10.1016/j.pulmoe.2020.10.005. Epub 2020 Nov 17.
2
Investigating the response to COVID-19 and understanding severe TB cases: The 2022 Pulmonology TB series.研究对COVID-19的反应并了解重症结核病病例：2022年肺病结核病系列
Pulmonology. 2022 May-Jun;28(3):155-157. doi: 10.1016/j.pulmoe.2022.01.018. Epub 2022 Feb 8.
3
Challenges and opportunities to end tuberculosis in the COVID-19 era.新冠疫情时代终结结核病面临的挑战与机遇
Lancet Respir Med. 2021 Jun;9(6):556-558. doi: 10.1016/S2213-2600(21)00161-2. Epub 2021 Mar 24.
4
TB and COVID-19 co-infection in a pulmonology hospital.一家肺病医院中的结核病与新冠病毒合并感染情况。
Int J Tuberc Lung Dis. 2023 Jul 1;27(7):574-576. doi: 10.5588/ijtld.23.0046.
5
Pulmonology in the 21st century and the mark left by COVID-19.21世纪的肺病学以及新冠疫情留下的印记。
J Bras Pneumol. 2022 Jan 7;47(6):e20210499. doi: 10.36416/1806-3756/e20210499.
6
Disseminated multidrug-resistant tuberculosis and SARS-CoV-2 co-infection in a child with IL-12Rβ1 deficiency.儿童白细胞介素-12 受体β1 缺陷症合并播散性耐多药结核分枝杆菌和严重急性呼吸综合征冠状病毒 2 感染
Indian J Tuberc. 2023 Jan;70(1):129-133. doi: 10.1016/j.ijtb.2022.04.008. Epub 2022 Apr 30.
7
Developing artificial intelligence technology for pediatric pulmonology: Lessons from COVID-19.为儿科肺病学开发人工智能技术：来自新冠疫情的经验教训。
Pediatr Pulmonol. 2022 Jul;57(7):1588-1589. doi: 10.1002/ppul.25901. Epub 2022 May 3.
8
Retrospective Cohort Study of Effects of the COVID-19 Pandemic on Tuberculosis Notifications, Vietnam, 2020.回顾性队列研究：COVID-19 大流行对 2020 年越南结核病报告病例的影响。
Emerg Infect Dis. 2022 Mar;28(3):684-692. doi: 10.3201/eid2803.211919.
9
Drug-resistant tuberculosis and COVID-19 co-infection: A systematic review of case reports.耐多药结核病与新型冠状病毒肺炎合并感染：病例报告的系统评价
Int J Mycobacteriol. 2021 Apr-Jun;10(2):214-215. doi: 10.4103/ijmy.ijmy_56_21.
10
Reenvisioning pediatric pulmonology: Reflections from an adult COVID-19 unit.重新构想儿科肺病学：来自成人 COVID-19 病房的思考。
Pediatr Pulmonol. 2020 Dec;55(12):3234-3235. doi: 10.1002/ppul.25113. Epub 2020 Oct 20.

引用本文的文献

1
Changes in incidence and clinical features of tuberculosis with regard to the COVID-19 outbreak in Southern Iran.伊朗南部 COVID-19 疫情暴发前后结核病发病率和临床特征的变化。
BMC Infect Dis. 2024 Sep 27;24(1):1043. doi: 10.1186/s12879-024-09947-0.
2
Drug-Resistant Tuberculosis and COVID-19: A Scoping Review on a New Threat to Antimicrobial Resistance.耐药结核病和 COVID-19：对抗菌药物耐药性新威胁的范围综述。
Rev Bras Enferm. 2023 Dec 4;76Suppl 1(Suppl 1):e20220803. doi: 10.1590/0034-7167-2022-0803. eCollection 2023.
3
Impact of the COVID-19 pandemic on in-hospital diagnosis of tuberculosis in non-HIV patients.2019年冠状病毒病疫情对非艾滋病病毒患者院内结核病诊断的影响
Pulmonology. 2022 Nov-Dec;28(6):481-483. doi: 10.1016/j.pulmoe.2022.04.012. Epub 2022 May 11.
4
Improving Assignments for Therapeutic and Prophylactic Treatment Within TB Households. A Potential for Immuno-Diagnosis?改善结核家庭中治疗和预防治疗的措施。免疫诊断的潜力？
Front Immunol. 2022 Mar 17;13:801616. doi: 10.3389/fimmu.2022.801616. eCollection 2022.
5
The Magnitude of MTB and Rifampicin Resistance MTB Using Xpert-MTB/RIF Assay Among Tuberculosis Suspected Patients in Gedeo Zone, Southern Ethiopia.埃塞俄比亚南部盖德奥地区疑似结核病患者中使用Xpert-MTB/RIF检测法检测的结核分枝杆菌及利福平耐药性的程度
Infect Drug Resist. 2021 Sep 24;14:3961-3969. doi: 10.2147/IDR.S327607. eCollection 2021.
6
Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study.评估 COVID-19 大流行对结核病服务的影响：一项全球研究。
Eur Respir J. 2021 Nov 11;58(5). doi: 10.1183/13993003.01786-2021. Print 2021 Nov.

本文引用的文献

1
TB and COVID-19 co-infection: rationale and aims of a global study.结核病与新型冠状病毒肺炎合并感染：一项全球研究的基本原理与目标
Int J Tuberc Lung Dis. 2021 Jan 1;25(1):78-80. doi: 10.5588/ijtld.20.0786.
2
Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020.2020 年 1 月至 4 月，冠状病毒病大流行对结核病服务的全球影响。
Emerg Infect Dis. 2020 Nov;26(11):2709-2712. doi: 10.3201/eid2611.203163. Epub 2020 Sep 11.
3
Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC).传染病和大流行病病毒感染：对结核病和肺部的影响：世界传染病和免疫障碍协会（WAidid）、全球结核病网络（GTN）以及欧洲临床微生物学和传染病学会分枝杆菌感染研究组（ESGMYC）成员的共识。
Eur Respir J. 2020 Oct 1;56(4). doi: 10.1183/13993003.01727-2020. Print 2020 Oct.
4
COVID-19 effects on tuberculosis care in Sierra Leone.新冠疫情对塞拉利昂结核病防治工作的影响。
Pulmonology. 2021 Jan-Feb;27(1):67-69. doi: 10.1016/j.pulmoe.2020.05.013. Epub 2020 Jun 6.
5
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.活动性肺结核、后遗症与 COVID-19 合并感染：49 例首批队列。
Eur Respir J. 2020 Jul 9;56(1). doi: 10.1183/13993003.01398-2020. Print 2020 Jul.
6
Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts.结核病、COVID-19 和移民：对两个队列中 69 例死亡患者的初步分析。
Pulmonology. 2020 Jul-Aug;26(4):233-240. doi: 10.1016/j.pulmoe.2020.05.002. Epub 2020 May 14.
7
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network.耐多药/广泛耐药结核病患者和接触者的管理：新十年面临的挑战。全球结核病网络 2020 年临床更新。
Int J Infect Dis. 2020 Mar;92S:S15-S25. doi: 10.1016/j.ijid.2020.01.042. Epub 2020 Feb 4.
8
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report.耐药结核病治疗中不良反应监测：第一份全球报告。
Eur Respir J. 2019 Dec 19;54(6). doi: 10.1183/13993003.01522-2019. Print 2019 Dec.
9
Managing latent tuberculosis infection and tuberculosis in children.儿童潜伏性结核感染和结核病的管理。
Pulmonology. 2018 Mar-Apr;24(2):106-114. doi: 10.1016/j.rppnen.2017.10.007. Epub 2018 Mar 2.
10
New drugs and perspectives for new anti-tuberculosis regimens.新型抗结核治疗方案的新药和新视角。
Pulmonology. 2018 Mar-Apr;24(2):86-98. doi: 10.1016/j.rppnen.2017.10.009. Epub 2018 Feb 24.